SBWire

Delcath Systems, Inc. (Delcath) is a specialty pharmaceutical and medical device company. It specializes in developing percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to treat primary and metastatic liver cancers. Delcath's patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the liver, while preventing them from entering the patient's bloodstream. Its clinical trial product, the Delcath Percutaneous Hepatic Perfusion System (the Delcath PHP System), also known as Hepatic Chemosaturation therapy allows physicians to deliver ultra-high doses of anti-cancer agents to the liver while controlling their systemic exposure. Delcath is headquartered in New York, the US.

GlobalData's new report, "North America Cardiovascular Surgery Procedures Outlook to 2020", provides key procedures data on the North America Cardiovascular Surgery. The report provides procedure volumes within market categories - Coronary Artery Bypass Graft (On Pump and Off Pump CABG) Procedures and On Pump (Isolated On Pump Valve and Isolated On Pump CHD) Procedures.

The onset and progression of Alzheimer’s disease processes occurs at the molecular level within brain cells. New revolutionary technology is now available to “mine” Alzheimer’s brain cells and see large numbers of molecules at a time, an important new step in possibly unlocking new insight into treatment for the disease. A new research collaboration with the University of Southampton, a leading biomedical and clinical research institution located in the United Kingdom along with Morgantown, VA-based Protea’s proprietary direct molecular imaging technology, LAESI, will study the molecular mechanisms of the aged brain, in order to identify markers that may indicate risk of developing Alzheimer’s disease.

Merit Medical Systems, Inc. (Merit Medical) is a medical device company. It undertakes the manufacturing and marketing of single-use medical devices for use in interventional and diagnostic procedures. Its product lines include inflation devices and accessories, diagnostic and therapeutic catheters and guide wires, pressure sensors, medication syringes, safety products, and needles. The company has expertise in four primary areas, namely, radiology, cardiology, pulmonology, and gastroenterology. The company markets and sells its products through direct sales force in the US and Europe and through a network of OEM partners and distributors in the Europe, Africa, Middle East, Asia, South and Central America, and Canada. Merit Medical is headquartered in Utah, the US.

Roche Diagnostics Limited (Roche Diagnostics) undertakes the research, development, manufacture and marketing of diagnostic products for the healthcare markets. It also manufactures research reagents and systems and supplies drugs for cancer and transplantation for the in-vitro and virology markets. The company provides services to individuals and health professionals to facilitate the detection, monitoring, and management of their patients' medical conditions. It offers its products and services to patients, healthcare professionals, hospital lab professionals, researchers and pharmacists. It has operations in the Americas, Asia Pacific, Africa, the Middle East and Europe. Roche Diagnostics is the diagnostics division of F. Hoffmann-La Roche Ltd. and is headquartered in Basel, Switzerland.

Hologic, Inc. (Hologic) is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems exclusively serving the healthcare needs of women. The company is also a leading developer of imaging technology for digital radiography and breast imaging applications. Hologic's core business units are concentrated on mammography and breast biopsy, osteoporosis assessment, surgical devices for gynecology, mini C-arm and extremity MRI imaging for orthopedic procedures. The company operates in North America, Europe, Central America, Australia and Asia. Hologic is headquartered in Bedford, the US.

DexCom, Inc. (DexCom) is a medical device company. It undertakes the design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. Its major products include DexCom G4 Platinum, DexCom G4 Platinum (Pediatric) and DexCom Seven Plus continuous glucose monitoring systems. The company's in-hospital product, GlucoClear, is a blood-based in-vivo automated glucose monitoring system. It also offers DexCom Studio software to download reports; and DexCom mobile application on iOS and Android platform. The company also offers data transfer services through its subsidiary SweetSpot Diabetes Care, Inc. DexCom is headquartered in San Diego, California, the US.

Analogic Corporation (Analogic) is a technology company. It undertakes the design and manufacture of medical imaging and security systems, and subsystems in the healthcare and airport security markets. It specializes in the areas of magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, digital mammography and automatic explosive detection systems (EDS) for airport security. The company sells these technologies to original equipment manufacturers and clinical end users directly under the BK Medical brand name. The company has marketing operations in the US, Canada, China, Germany, Belgium, the UK, Italy and Scandinavia. Analogic is headquartered in Peabody, Massachusetts, the US.

GlobalData's new report, "Mexico Cardiovascular Surgery Market Outlook to 2020", provides key market data on the Mexico Cardiovascular Surgery Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Beating Heart Surgery Systems, Cardiac Ablation Devices, Cardiopulmonary Bypass Equipment and Perfusion Disposables.

GlobalData's new report, "Canada Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the Canada Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.

Recognized as National Cataract Awareness Month, June is marked by a series of events, initiatives and activities all across the country to increase the level of awareness about cataracts and its damaging consequences. My IDentity Doctor, a leading provider of medical alert jewelry now supports national cataract awareness month and discusses about various aspects of the medical conditions.

Sorin S.p.A. (Sorin) is a medical equipment company that develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. The company focuses on two major therapeutic areas, namely, cardiac surgery and cardiac rhythm management. Its major products include artificial cardiac valves (mechanical and tissue valves); annuloplasty rings; extracorporeal blood circulation systems including heart-lung machines; oxygenators; pacemakers, defibrillators, cardiac resynchronization devices; arterial filters and tubes; and autologous transfusion systems including devices and disposables used to collect and purify blood. Annually, more than one million patients are treated with its devices in more than 80 countries. Sorin is headquartered in Milan, Italy.

Epistem Holdings Plc (Epistem) is a biopharmaceutical and biotechnology company providing contract research facilities and services to other pharmaceutical companies. It also undertakes the development of novel therapeutics used in oncology and wound healing. It operates through three reportable segments, namely, Preclinicial Research Services, Novel Therapies and Personalised Medicine. It provides molecular biomarkers to measure drug induced gene expression from individual plucked hairs. It specializes in the marketing of epithelial stem cells in the areas of oncology, gastrointestinal diseases and dermatological applications. It offers reliable, innovative research models to the pharmaceutical, biotechnology and healthcare industries. Its principal subsidiaries include Epistem Limited and Epistem Inc. Epistem headquartered in Manchester, the UK.

Novartis AG (Novartis) is a healthcare solutions company. It undertakes the discovery, development and commercialization of a wide range of novel and generic products across various therapeutic areas in the human and animal health market. The company's product portfolio includes innovative medicines, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products for the treatment of conditions related to oncology, neurosciences, ophthalmology, respiratory diseases, immunology and infections. The company sells its products in various countries, which are classified by the company into four reportable regions, namely, the US, Americas (except the US), Europe and Rest of the World. Novartis is headquartered in Basel, Switzerland.

GlobalData's new report, "India Cardiovascular Surgery Market Outlook to 2020", provides key market data on the India Cardiovascular Surgery Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Beating Heart Surgery Systems, Cardiac Ablation Devices, Cardiopulmonary Bypass Equipment and Perfusion Disposables.

GlobalData's new report, "North America Prosthetic Heart Valves Market Outlook to 2020", provides key market data on the North America Prosthetic Heart Valves market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves.

Debiotech S.A. (Debiotech) is a medical device company. The company focuses on developing therapeutic devices and diagnostic products. The products that the company offers include patch-pump, injection, multi-fluidic cassette type system, infusion pump and microsystems. It sells its product under the brand name JewelPUMP, NanoJect, DialEase, Debiopass, CT Expres III, DebioClip, IV Expres and Debiopass. The company develops products in the areas of implantable and external drug delivery systems using nanotechnologies, micromechanics and microelectromechanical systems. It identifies new technologies and ideas originating from scientists, universities, or inventors and brings them to an approval by the Product for Human use. The company also focuses on research and development. Debiotech is headquartered in Lausanne, Switzerland.

International Men’s Wealth Week is dedicated to increasing the level of awareness about the health issues of men and help in promoting a healthy way of lifestyle and wellbeing for boys and men all across the world. Sharing this spirit of ensuring good mental and physical health, My IDentity Doctor is offering a wide range of medical alert jewelry for men, and in support of International Men’s Wealth Week. These engraved medical IDs play a crucial role in informing paramedics and doctors about any chronic medical condition of the wearer, in case of medical emergencies.

GlobalData's new report, "Brazil Cardiovascular Surgery Market Outlook to 2020", provides key market data on the Brazil Cardiovascular Surgery Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Beating Heart Surgery Systems, Cardiac Ablation Devices, Cardiopulmonary Bypass Equipment and Perfusion Disposables.

GlobalData's new report, "EU5 Cardiovascular Prosthetic Devices Market Outlook to 2020", provides key market data on the EU5 Cardiovascular Prosthetic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Valve Repairs and Septal Occluders.

GlobalData's new report, "France Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020", provides key market data on the France Cardiovascular Monitoring and Diagnostic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems.

Cordis Corporation (Cordis) is a medical device company. It carries out the design, manufacture and marketing of breakthrough products for interventional medicine, minimally invasive computer-based imaging, and electrophysiology. Cordis's product line includes balloons, catheters, guide wires and stents used in cardiology, endovascular and neurovascular therapy. It also provides educational and training resources, including support for research and other initiatives. The company provides products in areas such as cardiology, endovascular and biologics delivery systems. The company classified its operations into five business divisions, namely, Cordis Cardiology, Cordis Endovascular, Conor Medsystems LLC, Biosense Webster, Inc., and Cordis Biologics Delivery Systems Group. Cordis is a wholly-owned subsidiary of Johnson & Johnson and is headquartered in Bridgewater, New Jersey, the US.

GlobalData's new report, "Italy Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the Italy Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.

Exact Sciences Corporation (Exact) is a molecular diagnostics company. It focuses on the early detection and prevention of colorectal cancer. The company's proprietary non-invasive stool-based deoxyribonucleic acid (sDNA) screening technology is used to detect presence of colorectal pre-cancer and cancer. Its Cologuard test includes methods detects pre-cancerous polyps, DNA that sheds into stool and four stages of colorectal cancer. Exact contains DNA markers and protein markers to detect blood in stool utilizing an antibody-based Fecal Immunochemical Test (FIT). EXACT is headquartered in Madinson, Wisconsin, the US.

Luminex Corporation (Luminex) is a medical devices company. The company develops, manufactures and markets its proprietary biological testing technologies. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. It operates its business through two reportable business segments, namely, the Technology and Strategic Partnerships (TSP) segment and the Assays and Related Products (ARP) segment. Its TRP segment's product portfolio consists of Luminex LX 100/200, FLEXMAP 3D and MAGPIX; xPONENT, MicroPlex microspheres, MagPlex microspheres, xTAG microspheres, SeroMAP microspheres, and calibration and control microspheres. The ARP segment comprises assay products including respiratory viral family, gastrointestinal pathogen detection family, MultiCode assays and products family, among others. Luminex offers its product and services in North America, Europe and Asia-Pacific. Luminex is headquartered in Texas, the US.